Showing results (61-70 of 140) with videos related to
Sort By:
Pageof 14
Molecular Carcinogenesis|April 16, 1998
Modulation of p53 protein conformation and DNA-binding activity by intracellular chelation of zincG W Verhaegh, M O Parat, M J Richard, et al.Oncogene|March 14, 2000
The cytoprotective aminothiol WR1065 activates p21waf-1 and down regulates cell cycle progression through a p53-dependent pathwayS North, F El-Ghissassi, O Pluquet, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 23, 1999
Mutation spectra resulting from carcinogenic exposure: from model systems to cancer-related genesE Dogliotti, P Hainaut, T Hernandez, et al.Cell Death & Disease|February 16, 2013
A meta-analysis of cancer risk associated with the TP53 intron 3 duplication polymorphism (rs17878362): geographic and tumor-specific effectsC Sagne, V Marcel, A Amadou, et al.Cancer Research|May 30, 1998
Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancerC Gratas, Y Tohma, C Barnas, et al.Acta Clinica Belgica|September 12, 2000
Heparin-induced thrombocytopaenia complicated by arterial and venous thrombosis: report of 2 cases successfully treated by a danaparoid sodiumK Darling, C Jaumotte, P Saussoy, et al.Cancer Research|June 15, 1990
A congenic line of the BALB/c mouse strain with the endogenous mouse mammary tumor virus proviral gene Mtv-3: tissue-specific expression and correlation with resistance to mouse mammary tumor virus infection and tumorigenesisP Hainaut, M Castellazzi, D Gonzales, et al.Cancer Gene Therapy|October 23, 2010
Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapiesI Goldstein, V Marcel, M Olivier, et al.Mutation Research|January 15, 2000
New approaches to understanding p53 gene tumor mutation spectraM Hollstein, M Hergenhahn, Q Yang, et al.Acta Clinica Belgica|January 1, 1996
Nocardiosis: a rare cause of pleuropulmonary disease in the immunocompromised hostA N Toukap, P Hainaut, M Moreau, et al.Pageof 14